Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Details)

v3.20.1
Stockholders' Equity (Details)
$ / shares in Units, $ in Millions
9 Months Ended
Mar. 31, 2020
USD ($)
$ / shares
shares
Stockholders' Equity (Details) [Line Items]  
Common stock, Shares | shares 5,520,000
Common stock, Value per share $ 6.25
Aggregate gross value | $ $ 34.5
Payments for Underwriting Expense | $ $ 2.3
Weighted average grant fair value (in dollars per share) $ 4.26
Dividend yield 0.00%
Restricted Stock Units (RSUs) [Member]  
Stockholders' Equity (Details) [Line Items]  
Aggregate of restricted stock units | shares 222,500
Weighted average grant fair value (in dollars per share) $ 4.26
Employees and Directors [Member]  
Stockholders' Equity (Details) [Line Items]  
Weighted average grant fair value (in dollars per share) $ 7.65
Minimum [Member]  
Stockholders' Equity (Details) [Line Items]  
Vesting period 4 years
Maximum [Member]  
Stockholders' Equity (Details) [Line Items]  
Vesting period 5 years
Employees and Directors [Member]  
Stockholders' Equity (Details) [Line Items]  
Aggregate of restricted stock units | shares 872,061